Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Carbonic Anhydrase Activation and the Drug Design

Author(s): Claudia Temperini, Andrea Scozzafava and Claudiu T. Supuran

Volume 14, Issue 7, 2008

Page: [708 - 715] Pages: 8

DOI: 10.2174/138161208783877857

Price: $65

Abstract

The activation mechanism of Carbonic Anhydrase was recently explained using kinetic, spectroscopic and X-ray techniques. It has been demonstrated that the activators molecules (CAAs) bind at the entrance of the enzyme active-site facilitating the ratedetermining step of CA catalitic cycle. Drug design studies have been performed in order to obtain strong CAAs belonging to several chemical classes: amino acids, azoles, amine and their derivatives, etc. Structure-activity correlations of different activators are discussed for the most studied Carbonic Anhydrase isozymes: isoform I and II. The physiological relevance of CA activation and the possible application of CAAs in Alzheimers desease and for other memory therapies are also treated.

Keywords: Carbonic anhydrase, X-ray structure, kinetic, enzyme activator, Alzheimer's desease


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy